Efficacy and Safety of IgPro10 in Adults With Systemic Sclerosis (SSc)
Public ClinicalTrials.gov record NCT04138485. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Multicenter, Double-Blind, Placebo Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of IgPro10 (Intravenous Immunoglobulin, Privigen®) for the Treatment of Adults With Systemic Sclerosis
Study identification
- NCT ID
- NCT04138485
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- CSL Behring
- Industry
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- IgPro10 Biological
- Placebo Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 19, 2019
- Primary completion
- Sep 15, 2020
- Completion
- Sep 15, 2020
- Last update posted
- Nov 16, 2020
2019 – 2020
United States locations
- U.S. sites
- 20
- U.S. states
- 15
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic Arizona - Scottsdale | Scottsdale | Arizona | 85259 | — |
| Pacific Arthritis Care Center | Los Angeles | California | 90045 | — |
| University of California | Los Angeles | California | 90095 | — |
| Stanford University Medical Center | Palo Alto | California | 94304 | — |
| University of Colorado | Aurora | Colorado | 80045 | — |
| Lombardi Cancer Center-Georgetown University | Washington D.C. | District of Columbia | 20007 | — |
| Alliance for Multispecialty Research | Wichita | Kansas | 67207 | — |
| Heartland Research Associates, LLC | Wichita | Kansas | 67207 | — |
| Louisiana State University Health Sciences Center | Shreveport | Louisiana | 71103 | — |
| John Hopkins Bayview Medical Center | Baltimore | Maryland | 21287 | — |
| Boston University Amyloidosis Center | Boston | Massachusetts | 02118 | — |
| University of Michigan Health System | Ann Arbor | Michigan | 48108 | — |
| Rutgers Clinical Research Center | New Brunswick | New Jersey | 08901 | — |
| Northwell Health | Great Neck | New York | 11021 | — |
| Hospital For Special Surgery | New York | New York | 10021 | — |
| Cleveland Clinic - Taussig Cancer Center | Cleveland | Ohio | 44195 | — |
| Altoona Center For Research | Duncansville | Pennsylvania | 16635 | — |
| University of Pennsylvania - Perelman Center | Philadelphia | Pennsylvania | 19104 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| The University Of Texas Medical School At Houston (Utms) | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 57 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04138485, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 16, 2020 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04138485 live on ClinicalTrials.gov.